Tag: Bayer

Bayer to sell men’s health product Nebido to Grünenthal in €500m deal

businessnewstoday- July 17, 2022 0

Bayer has agreed to sell Nebido (testosterone undecanoate), its men’s health product, to German pharma company Grünenthal for a price of up to €500 million. ... Read More

US agri and biotech innovator Andes Ag, Inc. raises $15m in Series A round

businessnewstoday- September 14, 2021 0

Andes Ag, Inc., an agriculture and biotechnology innovator based in California, has raised $15 million in a Series A round co-led by Bayer’s impact investment ... Read More

Chronos-3 trial results : Aliqopa, rituximab combo meets primary endpoint of PFS, says Bayer

businessnewstoday- April 11, 2021 0

Chronos-3 trial results : Bayer said that the investigational combination of Aliqopa (copanlisib) and rituximab considerably increased progression-free survival (PFS) in patients having relapsed indolent ... Read More

Bayer to acquire US gene therapy company Asklepios BioPharmaceutical in $4bn deal

pharmanewsdaily- October 26, 2020 0

German pharma giant Bayer has agreed to acquire US clinical-stage gene therapy company Asklepios BioPharmaceutical in a deal worth up to $4 billion. The portfolio ... Read More

Bayer to acquire KaNDy Therapeutics to add menopause drug candidate

pharmanewsdaily- August 11, 2020 0

Bayer has agreed to acquire KaNDy Therapeutics, a UK clinical-stage biotech company, in a deal worth up to $900 million, in a move to grow ... Read More

Bayer gets Lampit FDA approval for Chagas disease in pediatric patients

pharmanewsdaily- August 7, 2020 0

Lampit FDA approval : Bayer has bagged approval for its antiprotozoal medication Lampit (nifurtimox) from the US Food and Drug Administration (FDA) for the treatment ... Read More

Bayer completes sale of animal health business to Elanco

pharmanewsdaily- August 4, 2020 0

Bayer has wrapped up its previously announced $7.6 billion sale of its animal health business division to US-based Elanco Animal Health. The transaction, which was ... Read More

Macquarie to acquire Currenta from Bayer and Lanxess for €3.5bn

Raghuram Kadari- August 7, 2019 0

German pharma company Bayer and specialty chemicals company Lanxess have signed corresponding agreements with Macquarie Infrastructure and Real Assets (MIRA) to sell their stakes in ... Read More

New oral blood thinner rivaroxaban from Bayer and Jannsen shown to cut recurrence of life-threatening blood clots

pharmanewsdaily- March 19, 2017 0

Bayer and Janssen Pharmaceuticals have revealed that their jointly developed oral blood thinner Xarelto (rivaroxaban) had considerably brought down the risk of recurring formation of ... Read More